Dr. Jennifer Nelson explains how Kaiser Permanente scientists are helping the CDC and FDA keep an eye out for rare adverse events.
Susan Brandzel cues up our tunes as we look ahead to better days in the new year.
Kaiser Permanente Washington shows price may not be a barrier to primary care implementation, Dr. Kai Yeung reports.
Dr. Diana Buist reflects on the challenges of providing screening during a pandemic — and finds reason for optimism.
The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
This year’s honorees inspire us with their unwavering dedication to helping colleagues grow and achieve – even from a distance.
KPWHRI responded to the COVID-19 hurricane with actions to improve health worldwide.